Nanomedicine News

RSS

Nanosponge Delivers Sustained, Specific Release of Paclitaxel to Irradiated Tumors

Nanosponge Delivers Sustained, Specific Release of Paclitaxel to Irradiated Tumors

When loaded with an anticancer drug, a delivery system based on a novel material that its creators call a nanosponge is three to five times more effective at reducing tumor growth than direct injection of the same drug. That is the conclusion of a paper published in the journal Cancer Research.

16 Jul 2010

Sugar-Coated Nanocapsule Delivers Large Doses of Radioactivity to Tumors

Starting with simple carbon nanotubes, a team of researchers from the United Kingdom and Spain has developed a sugar-coated nanocapsule that can deliver large doses of radioactivity to tumors. The researchers envision de...

16 Jul 2010

Tekmira to Advance RNAi Therapeutic Using Lipid Nanoparticle Technology

Tekmira to Advance RNAi Therapeutic Using Lipid Nanoparticle Technology

Tekmira Pharmaceuticals Corporation (TSX: TKM), a leader in RNA interference (RNAi) therapeutics, today announced that it has been awarded a new contract with the United States Department of Defense (DoD) Chemical and Biological Defense Program (CBDP) through the U.S. Army Space and Missile Defense Command (SMDC).

16 Jul 2010

Researchers Develop New Arsenic Nanobins to Reduce Tumor Growth

You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to...

16 Jul 2010

Nanoscopic Bead Technology Can Act as a Diagnostic Tool

New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs – bringing vital new...

16 Jul 2010

Nano-Based Drug Delivery to be Discussed at AAPM’s 52nd Annual Meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July18 - 22, 2010 in Philadelphia, PA. AAPM is the premier organization in medical physics, a broadly-based scientific a...

15 Jul 2010

AlphaRx to Present GAI-122 Injectable Nanoemulsion at CRS Expo

AlphaRx, Inc. (OTCBB: ALRX) announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Strok...

14 Jul 2010

Novartis Receives Licenses for Developing Nanobodies

Ablynx [Euronext Brussels: ABLX] announced today that Novartis has obtained licenses to further develop and commercialise Nanobodies against two complex targets. This has triggered a total of EUR1 million in upfront...

14 Jul 2010

Nanotechnology Experts to Present at International Conference

Julianna Lisziewicz, PhD, President of Genetic Immunity, a biopharmaceutical company developing nanomedicine-based immunotherapies, is an invited speaker at this week’s 7th International Conference on Nanosciences &...

13 Jul 2010

New Joint Venture Formed by Midatech and Immunotope

Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and Immunotope Inc, a biotechnology company focused on the development of immunotherapy products, today announ...

13 Jul 2010

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.